These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15045959)

  • 1. [Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].
    Rai Y; Sagara Y; Sagara Y; Ooi Y
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):443-7. PubMed ID: 15045959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy].
    Yamasaki M; Yayoi E; Kishibuchi M; Nishi T; Yagyu T; Kawasaki K; Ostapenko V; Nishide T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1746-8. PubMed ID: 11708024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].
    Terazaki Y; Nagamatsu H; Ono H; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 2005 May; 32(5):675-7. PubMed ID: 15918571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of neoadjuvant CMF to avoid mastectomy.
    George ML; Hale PC; Gumpert JR; Hogbin BM; Deutsch GP; Yelland A
    Eur J Surg Oncol; 1999 Feb; 25(1):50-3. PubMed ID: 10188855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
    Hutchins LF; Green SJ; Ravdin PM; Lew D; Martino S; Abeloff M; Lyss AP; Allred C; Rivkin SE; Osborne CK
    J Clin Oncol; 2005 Nov; 23(33):8313-21. PubMed ID: 16293862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
    Wang B; Fu JF; Hong ZW
    Ai Zheng; 2009 Mar; 28(3):292-6. PubMed ID: 19619445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
    Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer.
    Gordon NH; Silverman P; Lasheen W; Meinert J; Siminoff LA
    Breast Cancer Res Treat; 2007 May; 102(3):301-12. PubMed ID: 17033926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast carcinoma in accessory gland: a case report].
    Sivelli R; Del Rio P; Arcuri MF; Corcione L
    G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
    Pierce LJ; Hutchins LF; Green SR; Lew DL; Gralow JR; Livingston RB; Osborne CK; Albain KS
    J Clin Oncol; 2005 Jan; 23(1):24-9. PubMed ID: 15545669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
    Rai Y; Emi Y; Nishijima N; Kai S; Kano T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
    Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M;
    Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Success of neoadjuvant chemotherapy in conversion of mastectomy to breast conservation surgery.
    Kaufmann P; Dauphine CE; Vargas MP; Burla ML; Isaac NM; Gonzalez KD; Rosing D; Vargas HI
    Am Surg; 2006 Oct; 72(10):935-8. PubMed ID: 17058739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
    J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.